Barlesi F - Search Results

1

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW, Carcereny Costa E, Park K, Alexandru A, Lupinacci L, de la Mora Jimenez E, Sakai H, Albert I, Vergnenegre A, Peters S, Syrigos K, Barlesi F, Reck M, Borghaei H, Brahmer JR, O'Byrne KJ, Geese WJ, Bhagavatheeswaran P, Rabindran SK, Kasinathan RS, Nathan FE, Ramalingam SS. Hellmann MD, et al. Among authors: barlesi f. N Engl J Med. 2019 Nov 21;381(21):2020-2031. doi: 10.1056/NEJMoa1910231. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562796 Free article. Clinical Trial.

2

Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?

Greillier L, Barlési F, Doddoli C, Durieux O, Torre JP, Gimenez C, Kleisbauer JP. Greillier L, et al. Among authors: barlesi f. Respiration. 2004 Mar-Apr;71(2):178-83. doi: 10.1159/000076681. Respiration. 2004. PMID: 15031575

3

Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.

Doddoli C, Barlesi F, Chetaille B, Garbe L, Thomas P, Giudicelli R, Fuentes P. Doddoli C, et al. Among authors: barlesi f. Ann Thorac Surg. 2004 Apr;77(4):1168-72. doi: 10.1016/j.athoracsur.2003.09.049. Ann Thorac Surg. 2004. PMID: 15063228

4

[Prognostic indicators in stage I non-small cell lung cancer].

Barlési F, Doddoli C, Greillier L, Astoul P, Giudicelli R, Fuentes P, Thomas P. Barlési F, et al. Rev Mal Respir. 2004 Feb;21(1):93-103. doi: 10.1016/s0761-8425(04)71239-5. Rev Mal Respir. 2004. PMID: 15260042 Review. French.

5

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy.

Barlési F, Tchouhadjian C, Doddoli C, Torre JP, Astoul P, Kleisbauer JP. Barlési F, et al. Br J Cancer. 2005 Jan 17;92(1):13-4. doi: 10.1038/sj.bjc.6602296. Br J Cancer. 2005. PMID: 15597098 Free PMC article.

6

Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?

Doddoli C, Aragon A, Barlesi F, Chetaille B, Robitail S, Giudicelli R, Fuentes P, Thomas P. Doddoli C, et al. Among authors: barlesi f. Eur J Cardiothorac Surg. 2005 Apr;27(4):680-5. doi: 10.1016/j.ejcts.2004.12.035. Eur J Cardiothorac Surg. 2005. PMID: 15784374

7

Second-line treatment for advanced non-small cell lung cancer: a systematic review.

Barlési F, Jacot W, Astoul P, Pujol JL. Barlési F, et al. Lung Cancer. 2006 Feb;51(2):159-72. doi: 10.1016/j.lungcan.2005.08.017. Epub 2005 Dec 19. Lung Cancer. 2006. PMID: 16360238 Review.

8

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.

Pujol JL, Barlesi F, Daurès JP. Pujol JL, et al. Among authors: barlesi f. Lung Cancer. 2006 Mar;51(3):335-45. doi: 10.1016/j.lungcan.2005.11.001. Epub 2006 Feb 14. Lung Cancer. 2006. PMID: 16478643

9

[Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer].

Tummino C, Barlesi F, Tchouhadjian C, Tasei AM, Gaudy-Marqueste C, Richard MA, Astoul P. Tummino C, et al. Among authors: barlesi f. Rev Mal Respir. 2007 May;24(5):635-8. doi: 10.1016/s0761-8425(07)91133-x. Rev Mal Respir. 2007. PMID: 17519817 French.

10

Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years.

Breen D, Barlési F, Zemerli M, Doddoli C, Torre JP, Thomas P, Astoul P. Breen D, et al. Among authors: barlesi f. Clin Lung Cancer. 2007 Mar;8(5):331-4. doi: 10.3816/CLC.2007.n.013. Clin Lung Cancer. 2007. PMID: 17562233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

458 results

Search Page